Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease.

Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease. J Clin Endocrinol Metab. 1982 Dec; 55(6):1100-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.